Cognitive Impact of Cerebral Small Vessel Disease Changes in Patients With Hypertension

• Published in: Hypertension (Dallas, Tex. 1979) Vol. 73; no. 2; pp. 342 - 349
• Main Authors: Jiménez-Balado, Joan, Riba-Llena, Iolanda, Abril, Oscar, Garde, Edurne, Penalba, Anna, Ostos, Elena, Maisterra, Olga, Montaner, Joan, Noviembre, Maria, Mundet, Xavier, Ventura, Oriol, Pizarro, Jesus, Delgado, Pilar
• Format: Journal Article
• Language: English
• Published: United States American Heart Association, Inc 01.02.2019
• Subjects: cerebral small vessel diseases; magnetic resonance imaging; longitudinal cohort study; cognitive dysfunction; hypertension; white matter hyperintensities
• ISSN: 0194-911X; 1524-4563
• DOI: 10.1161/HYPERTENSIONAHA.118.12090

Hypertension is one of the principal risk factors for cerebral small vessel disease progression and cognitive impairment. We aimed to investigate how changes in cerebral small vessel disease lesions relate to cognitive decline and incident mild cognitive impairment in hypertensive patients. Data were obtained from the ISSYS cohort (Investigating Silent Strokes in Hypertensivesa Magnetic Resonance Imaging Study)—a longitudinal population-based study on hypertensive patients aged 50 to 70 years without dementia and stroke at baseline. Patients underwent a brain magnetic resonance imaging, a cognitive screening test, and cognitive diagnosis (normal aging or mild cognitive impairment) at baseline and follow-up. We evaluated incident lacunar infarcts and cerebral microbleeds. Changes in the periventricular and deep white matter hyperintensities (WMH) were qualitatively defined as none, minor, or marked. We followed up 345 patients (median age, 65 [61–68]; 55.4% men) for 3.95 (3.83–4.34) years. Incident mild cognitive impairment was diagnosed in 9.1% of the sample. Considering the progression of cerebral small vessel disease, the prevalence of incident infarcts was 6.1% and that of incident cerebral microbleeds was 5.5%; progression of periventricular WMH was 22% and that of deep WMH was 48%. Patients with marked progression of periventricular WMH showed a significant decrease in global cognition compared with patients without progression (adjusted mean [SE], −0.519 [0.176] versus 0.057 [0.044], respectively; P value=0.004) and a higher risk of incident mild cognitive impairment (OR, 6.184; 95% CI, 1.506–25.370; P value=0.011). Therefore, our results indicate that hypertensive patients with progression of periventricular WMH have higher odds of cognitive impairment, even in the early stages of cognitive decline.